Bisaro Paul
SEC insider (Form 3/4/5 filer). CIK 0001237253. Director at Keenova Therapeutics plc (NONE) and 2 other issuers. 22 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in BRIDGEWATER, NJ.
Companies Bisaro Paul has filed insider reports for
- Keenova Therapeutics plc (NONE): Director
- MYRIAD GENETICS INC (MYGN): Director
- Zoetis Inc. (ZTS): Director
Bisaro Paul
CIK: 0001237253
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jul 15, 2026No ticker
Keenova Therapeutics plc
AwardDirectRestricted Stock Units
4.4K shares- - Jun 4, 2026MYGN
MYRIAD GENETICS INC
AwardDirect59.7K shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
DispositionDirectRestricted Stock Units
2.2K shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
Tax PaymentDirect619 shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
ExerciseDirect2.7K shares- - May 14, 2026MYGN
MYRIAD GENETICS INC
PurchaseDirect7.5K shares at avg. $3.69$28K - May 13, 2026ZTS
Zoetis Inc.
PurchaseDirect2K shares at avg. $75.88$152K - Feb 23, 2026No ticker
Keenova Therapeutics plc
AwardDirectRestricted Stock Units
4K shares- - Feb 19, 2026ZTS
Zoetis Inc.
ExerciseDirect1.6K shares- - Feb 18, 2026ZTS
Zoetis Inc.
AwardDirectRestricted Stock Unit
1.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  No ticker Keenova Therapeutics plc | Award Restricted Stock Units | 4,406 | - | - | Direct |
| Jun 4, 2026 |  MYGN MYRIAD GENETICS INC | Award | 59,701 | - | $0 | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Disposition Restricted Stock Units | 2,197 | - | - | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Tax Payment | 619 | - | $0 | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Exercise | 2,685 | - | $0 | Direct |
| May 14, 2026 | MYGN MYRIAD GENETICS INC | Purchase | 7,500 | $3.69 | $27,638 | Direct |
| May 13, 2026 |  ZTS Zoetis Inc. | Purchase | 2,000 | $75.88 | $151,750 | Direct |
| Feb 23, 2026 | No ticker Keenova Therapeutics plc | Award Restricted Stock Units | 3,984 | - | - | Direct |
| Feb 19, 2026 | ZTS Zoetis Inc. | Exercise | 1,619 | - | $0 | Direct |
| Feb 18, 2026 | ZTS Zoetis Inc. | Award Restricted Stock Unit | 1,936 | - | - | Direct |
1-10 of 22 transactions